The European Commission has given its final approval to the rollout of the Pfizer Bio-N-Tech vaccine.
The authorisation makes the jab legally binding across all member states, and follows the conditional approval by the European Medicines Agency yesterday. Its rollout here is expected in the 'coming days', with the first 10,000 doses due to arrive before the end of the year.
